Resolve Therapeutics Finds $5.8M

Seattle-based Resolve Bio has raised $5.8M more for its efforts to develop treatments for lupus, according to a report today. The funding came from WRF Capital, New Science Ventures, and Easton Capital. New of the funding first came from Xconomy. Resolve Bio is developing treatments for lupus erythematosus, and is based on research from the University of Washington. The firm has now raised $7.8M in funding. More information »